The Goldman Sachs Group Has Lowered Expectations for MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Price
MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) had its price target decreased by equities researchers at The Goldman Sachs Group from $82.00 to $73.00 in a report issued on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. The Goldman Sachs Group’s target price points to a potential upside of 74.81% from […]
MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) had its price target decreased by equities researchers at The Goldman Sachs Group from $82.00 to $73.00 in a report issued on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. The Goldman Sachs Group’s target price points to a potential upside of 74.81% from […]
